tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks 50 IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFs
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA

PRME Stock Latest News

Prime Medicine’s Technological Edge and Strategic Positioning Highlighted as Key Investment Opportunity
RatingsPrime Medicine’s Technological Edge and Strategic Positioning Highlighted as Key Investment Opportunity
1d ago
PRME
Prime Medicine Elects Directors at Annual Meeting
PremiumCompany Announcements
Prime Medicine Elects Directors at Annual Meeting
13d ago
8K
PRME
Altria, Prime Medicine, US Steel, DLocal, Prothena: Trending by Analysts
PremiumWeekend Updates
Altria, Prime Medicine, US Steel, DLocal, Prothena: Trending by Analysts
19d ago
X
MO
Prime Medicine downgraded to Neutral from Buy at Citi
PremiumThe Fly
Prime Medicine downgraded to Neutral from Buy at Citi
23d ago
PRME
Hold Rating for Prime Medicine, Inc. Amid Financial Uncertainties and Strategic Adjustments
PremiumRatings
Hold Rating for Prime Medicine, Inc. Amid Financial Uncertainties and Strategic Adjustments
23d ago
PRME
Hold Rating on Prime Medicine, Inc. Amid Strategic Shifts and Financial Reevaluation
PremiumRatingsHold Rating on Prime Medicine, Inc. Amid Strategic Shifts and Financial Reevaluation
26d ago
PRME
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
27d ago
TIL
ARMP
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
28d ago
SNY
ARMP
Prime Medicine downgraded to Neutral from Buy at H.C. Wainwright
PremiumThe Fly
Prime Medicine downgraded to Neutral from Buy at H.C. Wainwright
29d ago
PRME
Prime Medicine price target lowered to $6 from $10 at Citizens JMP
PremiumThe Fly
Prime Medicine price target lowered to $6 from $10 at Citizens JMP
30d ago
PRME
Prime Medicine, Inc.: Hold Rating Amid Strategic Restructuring and Long-term Uncertainty
PremiumRatings
Prime Medicine, Inc.: Hold Rating Amid Strategic Restructuring and Long-term Uncertainty
30d ago
PRME
Prime Medicine downgraded to Neutral from Overweight at JPMorgan
PremiumThe Fly
Prime Medicine downgraded to Neutral from Overweight at JPMorgan
1M ago
PRME
Prime Medicine price target lowered to $12 from $16 at Chardan
PremiumThe FlyPrime Medicine price target lowered to $12 from $16 at Chardan
1M ago
EDIT
PRME
Prime Medicine Appoints New CEO Amid Restructuring
Premium
Company Announcements
Prime Medicine Appoints New CEO Amid Restructuring
1M ago
8K
PRME
Prime Medicine, Inc.: Strategic Shifts and Leadership Changes Bolster Long-term Buy Rating Amid Near-term Volatility
Premium
Ratings
Prime Medicine, Inc.: Strategic Shifts and Leadership Changes Bolster Long-term Buy Rating Amid Near-term Volatility
1M ago
PRME
Prime Medicine CEO Keith Gottesdiener to step down, Allan Reine to succeed
PremiumThe Fly
Prime Medicine CEO Keith Gottesdiener to step down, Allan Reine to succeed
1M ago
PRME
Prime Medicine to deprioritize CGD programs, reduce headcount by 25%
PremiumThe Fly
Prime Medicine to deprioritize CGD programs, reduce headcount by 25%
1M ago
PRME
Prime Medicine announces initial data from Phase 1/2 study of PM359
PremiumThe Fly
Prime Medicine announces initial data from Phase 1/2 study of PM359
1M ago
PRME
Prime Medicine’s Promising Clinical Data and Favorable Market Conditions Make It a Buy
PremiumRatings
Prime Medicine’s Promising Clinical Data and Favorable Market Conditions Make It a Buy
1M ago
PRME
Prime Medicine, Inc.: Buy Rating Backed by Promising Gene Editing Advancements and Robust Pipeline
PremiumRatingsPrime Medicine, Inc.: Buy Rating Backed by Promising Gene Editing Advancements and Robust Pipeline
1M ago
PRME
Prime Medicine Reports Q1 2025 Financial Results
Premium
Company Announcements
Prime Medicine Reports Q1 2025 Financial Results
1M ago
PRME
Prime Medicine reports Q1 EPS (40c), consensus (31c)
Premium
The Fly
Prime Medicine reports Q1 EPS (40c), consensus (31c)
1M ago
PRME

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >